ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Zavesca, Kapseln - 84 Kapsel(n)
56898001 Janssen-Cilag AG
Zavesca, Kapseln22.10.2004
Original22.10.2004
Miglustat (A16AX06) 
WHO-DDD 
07.99.84 Kapsel(n)
07.99. 
B  
Yes 
IPCI
4501.01Yes
    
10 %4864.30
7680568980018Synthetika
2900363 
Composition
miglustatum 100 mg, carboxymethylamylum natricum A, povidonum K 30, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: E 172 (nigrum), lacca, pro capsula corresp. natrium 190 µg.
Packungsbestandteile
Capsules 
  
 
Active AgentDose
Miglustate100 mg
BAG: Active AgentDose
Miglustate100 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
Carboxymethylamylum Natricum A  
E 171 color.
E 172 Drucktinte
Gelatina Kapselhülle
Lacca  
Magnesii Stearas  
Povidonum K30  
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home